Organ dysfunction, thrombotic events and malignancies in patients with idiopathic multicentric castleman disease: a population-level US health claims analysis

被引:8
|
作者
Mukherjee, Sudipto [1 ]
Kanhai, Karan [2 ]
Kauffman, David [3 ]
Martin, Rabecka [4 ]
Paige, Jeremy S. [3 ]
Ghosh, Anirvan [3 ]
Kannan, Hannah [3 ]
Shupo, Francis [2 ]
Fajgenbaum, David C. [5 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[2] EUSA Pharma, Hemel Hempstead, England
[3] Eversana LLC, Milwaukee, WI USA
[4] EUSA Pharma, Burlington, MA USA
[5] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41375-022-01690-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2539 / 2543
页数:5
相关论文
共 41 条
  • [1] Organ dysfunction, thrombotic events and malignancies in patients with idiopathic multicentric castleman disease: a population-level US health claims analysis
    Sudipto Mukherjee
    Karan Kanhai
    David Kauffman
    Rabecka Martin
    Jeremy S. Paige
    Anirvan Ghosh
    Hannah Kannan
    Francis Shupo
    David C. Fajgenbaum
    Leukemia, 2022, 36 : 2539 - 2543
  • [2] Correction to: Organ dysfunction, thrombotic events, and malignancies in patients with idiopathic multicentric Castleman disease: a population-level US health claims analysis
    Sudipto Mukherjee
    Karan Kanhai
    David Kauffman
    Rabecka Martin
    Jeremy S. Paige
    Anirvan Ghosh
    Hannah Kannan
    Francis Shupo
    David C. Fajgenbaum
    Leukemia, 2023, 37 : 253 - 253
  • [3] Organ dysfunction, thrombotic events, and malignancies in patients with idiopathic multicentric Castleman disease: a population-level US health claims analysis (vol 36, pg 2539, 2022)
    Mukherjee, Sudipto
    Kanhai, Karan
    Kauffman, David
    Martin, Rabecka
    Paige, Jeremy S.
    Ghosh, Anirvan
    Kannan, Hannah
    Shupo, Francis
    Fajgenbaum, David C.
    LEUKEMIA, 2023, 37 (01) : 253 - 253
  • [4] Emerging morbidities and health care resource utilization in idiopathic multicentric Castleman disease patients: A population-level analysis using health claims-based dataset.
    Mukherjee, Sudipto
    Kanhai, Karan
    Kauffman, David
    Martin, Rabecka
    Paige, Jeremy S.
    Ghosh, Anirvan
    Kannan, Hannah
    Shupo, Francis
    Fajgenbaum, David
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18792 - E18792
  • [5] A longitudinal population level analysis of healthcare resource utilization and morbidities in idiopathic multicentric castleman disease patients
    Mukherjee, S.
    Martin, R.
    Sande, B.
    Paige, J.
    Fajgenbaum, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 192 - 193
  • [6] A Longitudinal Population Level Analysis of Healthcare Resource Utilization and Morbidities in Idiopathic Multicentric Castleman Disease Patients.
    Mukherjee, Sudipto
    Martin, Rabecka
    Sande, Brenda
    Paige, Jeremy
    Fajgenbaum, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 100 - 100
  • [7] A Longitudinal Population Level Analysis of Healthcare Resource Utilization, Comorbidity, and Survival in Idiopathic Multicentric Castleman Disease Patients
    Mukherjee, Sudipto
    Martin, Rabecka
    Sande, Brenda
    Glen, Chad
    Paige, Jeremy
    Yarlagadda, Suresh
    Fajgenbaum, David C.
    BLOOD, 2020, 136
  • [8] Patterns of Disease Progression in Patients with Systemic Mastocytosis: A US Population-Level Analysis Using Health Claims-Based Dataset
    Mukherjee, Sudipto
    Cattie, Doug
    Pemmaraju, Naveen
    Green, Teresa
    Shaheen, Dan
    BLOOD, 2022, 140 : 6865 - 6867
  • [9] Patterns of Disease Progression in Patients with Non-Advanced Systemic Mastocytosis: A US Population-level Analysis Using Health Claims-Based Dataset
    Mukherjee, Sudipto
    Cattie, Douglas
    Pemmaraju, Naveen
    Shaheen, Daniel
    Green, Teresa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB49 - AB49
  • [10] Cost of treating thrombotic events in a US population of von Willebrand disease patients
    Khachatryan, A.
    Xiong, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 495 - 495